Plain-English translation of NCT07753330 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to exposure therapy—a proven treatment for anxiety disorders. Researchers want to see if focusing on changing your expectations during therapy sessions leads to better, longer-lasting results than traditional exposure therapy methods.
While exposure therapy is effective for anxiety, many people experience their anxiety symptoms returning over time. This study aims to understand whether a newer approach that emphasizes changing what patients expect to happen during treatment can prevent that return of fear and maintain improvements longer.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups: a new exposure therapy approach, traditional exposure therapy, or a waiting list that begins treatment after 12 weeks. If you receive active treatment, you will attend weekly therapy sessions where you'll gradually confront situations or triggers that make you anxious. The study follows you over time to see how well your anxiety improves and whether those improvements last.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
Chile
Sponsor
University of Chile
Collaborators
Universidad de los Andes, Chile
Enrollment target
~203 participants
Started
July 2026
Primary completion
July 2028
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Vanetza E Quezada-Scholz, PhD
University of Chile
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.